1387 Late Recurrence of Metastatic Pancreatic Angiomyolipoma in Tuberous Sclerosis Following Bilateral Nephrectomy and Transplant
نویسندگان
چکیده
منابع مشابه
Bilateral angiomyolipoma , tuberous sclerosis , and pregnancy
El angiomiolipoma es un tumor renal benigno relativamente infrecuente, con incidencia aumentada en pacientes con esclerosis tuberosa. Éste es un desorden autosómico dominante, caracterizado por lesiones hamartomatosas en múltiples órganos y frecuentemente afectando el riñón. El estado de gravidez es una condición que puede agudizar la sintomatología ante tumores renales previamente silentes, po...
متن کاملTuberous sclerosis with bilateral renal angiomyolipoma.
Tuberous sclerosis is 2nd most common neurocutaneous syndrome. Bilateral renal angiomyolipoma in tuberous sclerosis is a rare entity. Reporting two cases of tuberous sclerosis with bilateral renal angiomyolipomas.
متن کاملBilateral renal angiomyolipoma presenting as tuberous sclerosis syndrome.
To cite: Prakash G, Sankhwar S, Jhanwar A, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2016214778 DESCRIPTION A 30-year-old woman presented with generalised abdominal pain of 3-month duration. She had a history of epilepsy and low intelligence since childhood. On examination, she was found to have multiple painless papules on her face (figure 1) and per...
متن کامل[Bilateral giant renal angiomyolipoma following hemodialysis in a patient with tuberous sclerosis].
A 49-year-old woman with tuberous sclerosis visited our hospital complaining of left abdominal pain. She had been diagnosed with bilateral renal angiomyolipoma (AML) when she was 32 years old and had been on maintenance hemodialysis since the age of 44. Magnetic resonance imaging showed bilateral giant renal AML and hemorrhage in the AML of the left kidney. Transthoracolumbar left nephrectomy w...
متن کاملEverolimus for renal angiomyolipoma in tuberous sclerosis.
In The Lancet, John Bissler and colleagues report the fi rst randomised, double-blind, placebo-controlled, phase 3 trial of everolimus, an inhibitor of mammalian target of rapamycin (mTOR), in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis, and angiomyolipoma. Their fi ndings suggest a clear advantage for everolimus over placebo in reducing angiomyolipoma volume w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Gastroenterology
سال: 2019
ISSN: 0002-9270,1572-0241
DOI: 10.14309/01.ajg.0000595076.76477.bd